Innoviva (INVA) Total Liabilities (2010 - 2026)
Innoviva (INVA) posted Total Liabilities of $200000.0 for Q1 2026, little changed on a QoQ basis from $200000.0 in Q4 2025, and little changed year-over-year from $200000.0 in Q1 2025.
Innoviva (INVA) Total Liabilities (2010 - 2026) Analysis & Trends
Innoviva's Total Liabilities history runs 17 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- Quarterly Total Liabilities changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $200000.0, changed 0.0% from the prior year.
- Total Liabilities was $200000.0 for Q1 2026 at Innoviva, roughly flat from $200000.0 in the prior quarter.
- Across five years, Total Liabilities topped out at $18.7 million in Q2 2022 and bottomed at $100000.0 in Q4 2023.
- A 5-year average of $2.5 million and a median of $600000.0 in 2024 frame the typical range for Total Liabilities.
- Peak annual rise in Total Liabilities reached 700.0% in 2022, while the deepest fall reached 99.98% in 2022.
- Innoviva's Total Liabilities stood at $1.6 million in 2022, then slumped by 93.75% to $100000.0 in 2023, then jumped by 100.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows INVA's Total Liabilities at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 18.70 Mn |
| Mar 31, 2022 | 12.43 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 887.24 Mn |
| Jun 30, 2021 | 789.15 Mn |